Beyond adding years to life: Health-related quality-of-life and functional outcomes in patients with severe aortic valve stenosis at high surgical risk undergoing transcatheter aortic valve replacement

Current Cardiology Reviews

Volumn 9, Issue 4, 2013, Pages 281-294

  Deutsch, Marcus André ^a   Bleiziffer, Sabine ^a   Elhmidi, Yacine ^a   Piazza, Nicolo ^a   Voss, Bernhard ^a   Lange, Ruediger ^a   Krane, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aortic valve stenosis; Functional outcomes; Health related quality of life; Transcatheter aortic valve implantation

Indexed keywords

AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CARDIAC PATIENT; CLINICAL DECISION MAKING; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; EMOTIONAL STABILITY; FUNCTIONAL ASSESSMENT; GERIATRIC PATIENT; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; LIFE EXPECTANCY; MENTAL HEALTH; OUTCOME ASSESSMENT; PATIENT REFERRAL; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; SEVERE AORTA VALVE STENOSIS; SOCIAL INTERACTION; SURGICAL AORTIC VALVE REPLACEMENT; SURGICAL RISK; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGE FACTORS; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; HEALTH STATUS; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84895505524     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/1573403X09666131202121750     Document Type: Article

References (67)

1. Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009; 373): 956-66.
2. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-607.
3. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS; 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008; 118:e523-661.
4. Authors/Task Force Members, Vahanian A, Alfieri O, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012.
5. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009; 137: 82-90.
6. Dunning J, Gao H, Chambers J, et al. Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use--an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database. J Thorac Cardiovasc Surg 2011; 142: 776-82.
7. Vasques F, Messori A, Lucenteforte E, Biancari F. Immediate and late outcome of patients aged 80 years and older undergoing isolated aortic valve replacement: a systematic review and metaanalysis of 48 studies. Am Heart J 2012; 163: 477-85.
8. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005; 26: 2714-20.
9. Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol 2007; 50: 2018-9.
10. Bouma BJ, van den Brink RBA, van der Meulen JHP, et al. To operate or not elderly patient with aortic stenosis: the decision and its consequences. Heart 1999; 82: 143-8.
11. Buellesfeld L, Windecker S. Transcatheter aortic valve implantation: the evidence is catching up with reality Eur Heart J 2011; 32: 133-7.
12. Rodés-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 2011; 9: 15-29.
13. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011; 124: 425-33.
14. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011; 32: 198-204.
15. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686-95.
16. Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aorticvalve replacement for inoperable severe aortic stenosis. N Engl J Med 2012; 366: 1696-704.
17. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-15.
18. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011; 58: 2130-8.
19. Bleiziffer S, Mazzitelli D, Opitz A, et al. Beyond the short-term: clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients. J Thorac Cardiovasc Surg 2012; 143: 310-7.
20. Ussia GP, Barbanti M, Petronio AS, et al. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J 2012; 33: 969-76.
21. Hecker SM, Sade RM. Ethical Issues in Cardiothoracic Surgery for the Elderly. Part II: Physiologic Changes In: Katlic MR. Cardiothoracic Surgery in the Elderly. Springer, New York: 2011; 94.
22. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008; 29: 1463-70.
23. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011; 57: 253-69.
24. Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/ SCAI/STS expert consensus document on transcatheter aortic valve replacement: Developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Thorac Cardiovasc Surg 2012; 144: e29-84.
25. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-43.
26. Sündermann S, Dademasch A, Praetorius J, et al. Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery. Eur J Cardiothorac Surg 2011; 39: 33-7.
27. Hecker SM, Sade RM. Ethical Issues in Cardiothoracic Surgery for the Elderly. Part II: Physiologic Changes In: Katlic MR. Cardiothoracic Surgery in the Elderly. Springer, New York.
28. Gurvitch R, Webb JG. Life after transcatheter aortic valve implantation: quality still matters. Heart 2010; 96: 1083-4.
29. Elkinton JR. Medicine and the quality of life. Ann Intern Med 1966; 64: 711-4.
30. Koch CG, Khandwala F, Blackstone EH. Health-related quality of life after cardiac surgery. Semin Cardiothorac Vasc Anesth 2008; 12: 203-17.
31. Haywood KL, Garratt AM, Fitzpatrick R. Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res 2005; 14: 1651-68.
32. Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JP. Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ 2009; 338: a3006.
33. Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-33.
34. Rector TS, Tschumperlin LK, Kubo SH, et al. Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail 1995; 1: 201-6.
35. Guyatt GH. Measurement of health-related quality of life in heart failure. J Am Coll Cardiol 1993; 22: 185Ae191A.
36. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000; 35: 1245-55.
37. Spertus J, Peterson E, Conard MW, et al. Cardiovascular Outcomes Research Consortium. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J 2005; 150: 707-15.
38. The EuroQol Group. Euro-Qol: a new facility for measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
39. Ware J, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. Determining important differences in scores. In: User's Manual for the SF-36v2 Health Survey. Lincoln, RI: QualityMetric Incorporated, 2007.
40. Wyrwich KW, Spertus JA, Kroenke K, Tierney WM, Babu AN, Wolinsky FD. Clinically important differences in health status for patients with heart disease: an expert consensus panel report. Am Heart J 2004; 147: 615-22.
41. Reynolds MR, Magnuson EA, Lei Y, et al. Placement of Aortic Transcatheter Valves (PARTNER) Investigators. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 2011; 124: 1964-72.
42. Reynolds MR, Magnuson EA, Wang K, et al. Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic Stenosis: Results From the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol 2012; 60: 548-58.
43. Ussia GP, Mulè M, Barbanti M, et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J 2009; 30: 1790-6.
44. Ussia GP, Barbanti M, Cammalleri V, et al. Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis. EuroIntervention 2011; 7: 573-9.
45. Gotzmann M, Hehen T, Germing A, et al. Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis. Heart 2010; 96: 1102-6.
46. Gotzmann M, Bojara W, Lindstaedt M, et al. One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis. Am J Cardiol 2011; 107: 1687-92.
47. Krane M, Deutsch MA, Bleiziffer S, et al. Quality of life among patients undergoing transcatheter aortic valve implantation. Am Heart J 2010; 160: 451-7.
48. Krane M, Deutsch MA, Piazza N, et al. One-year results of healthrelated quality of life among patients undergoing transcatheter aortic valve implantation. Am J Cardiol 2012; 109: 1774-81.
49. Bekeredjian R, Krumsdorf U, Chorianopoulos E, et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age. Am J Cardiol 2010; 106: 1777-81.
50. Lefèvre T, Kappetein AP, Wolner E, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011; 32: 148-57.
51. Gonçalves A, Marcos-Alberca P, Almeria C, et al. Quality of life improvement at midterm follow-up after transcatheter aortic valve implantation. Int J Cardiol 2011.
52. Georgiadou P, Kontodima P, Sbarouni E, et al. Long-term quality of life improvement after transcatheter aortic valve implantation. Am Heart J 2011; 162: 232-7.
53. Fairbairn TA, Meads DM, Mather AN, et al. Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes. J Am Coll Cardiol 2012; 59: 1672-80.
54. Amonn K, Stortecky S, Brinks H, et al. Quality of life in high-risk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement. Eur J Cardiothorac Surg 2012.
55. Stortecky S, Schmid V, Windecker S, et al. Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation. EuroIntervention 2012; 8: 437-43.
56. Taramasso M, Latib A, Cioni M, et al. Quality of life improvement is maintained up to two years after transcatheter aortic valve implantation in high-risk surgical candidates. EuroIntervention 2012; 8: 429-36.
57. Fairbairn TA, Mather AN, Bijsterveld P, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 2012; 98: 18-23.
58. Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2012; 98: 370-6.
59. Brazier JE, Ratcliffe J, Tsuchiya A, Salomon J. Measuring and Valuing Health Benefits for Economic Evaluation. Oxford: Oxford University Press, 2007.
60. Reynolds MR, Magnuson EA, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation 2012; 125: 1102-9.
61. Hlatky MA, Simons CT. Cost-effectiveness of transcatheter aortic valve replacement. Circulation 2012; 125: 1076-7.
62. Gada H, Kapadia SR, Tuzcu EM, Svensson LG, Marwick TH. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol 2012; 109: 1326-33.
63. Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A costutility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2012; 2: e001032.
64. Van Brabandt H, Neyt M, Hulstaert F. Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ 2012; 345: e4710.
65. Beckmann A, Hamm C, Figulla HR, et al. The German Aortic Valve Registry (GARY): A Nationwide Registry for Patients Undergoing Invasive Therapy for Severe Aortic Valve Stenosis. Thorac Cardiovasc Surg 2012; 60: 319-25.
66. van Mieghem NM, Head SJ, van der Boon RM, et al. The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis. EuroIntervention 2012; 8: 258-66.
67. Lange R, Bleiziffer S, Mazzitelli D, et al. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. J Am Coll Cardiol 2012; 59: 280-7.